Home HOMEPAGE   Tue, 10/22/2019 GMT + 7
    Q & A   Site map Forum   Site map Sitemap   E-mali Contact   Vietnamese Vietnamese
IMPE-QN
Web Sites & Commerce News - Events
Web Sites & Commerce Introduction
Finance & Retail Collaborative activities
National collaboration
International collaboration
Malaria control for ethnic minorities
Global Funds for Malaria control
Web Sites & Commerce Training
Web Sites & Commerce Specific research studies
Web Sites & Commerce Publications
Web Sites & Commerce Mass organization activities
Web Sites & Commerce Legal documents
Web Sites & Commerce Statistical data
Web Sites & Commerce Work safety
Web Sites & Commerce Vietnam`s Physicians
Web Sites & Commerce Malariology
Web Sites & Commerce Helminthology
Web Sites & Commerce Other vector-borne diseases

SEARCH

LOGIN
Username
Password

WEBLINKS
Other links

Visiting users: 128
3 9 0 6 7 6 2 8
Online
1 2 8
 Collaborative activities Global Funds for Malaria control
A government health worker takes a blood sample to be tested for malaria in Ta Gay Laung village hall in Hpa-An district in Kayin state, south-eastern Myanmar, November 28, 2014. REUTERS/Astrid Zweynert
A partnership to end malaria in the Mekong

The Global Fund to Fight AIDS, Tuberculosis and Malaria - Mosquito-borne parasites know no borders, as the Zika virus in Latin America has reminded us this year. While the impact of Zika is still being assessed, we know that malaria kills hundreds of thousands of people a year, most of them young children. Malaria is a preventable and treatable disease, and we are determined to end it.

We have to look past borders, just like infectious diseases do.

Our most effective weapon against malaria - building o­n preventive measures and rapid treatment - is strong partnerships that can constantly adapt to changing situations o­n the ground.

The Greater Mekong region in South East Asia is a lesson in how partnerships and new thinking can come together to confront global health risks. After years of careful investments, the malaria situation in the Greater Mekong region has improved dramatically, with sharp declines in cases and deaths. However, the region still faces huge challenges, with high transmission taking place along borders and in remote forests.

Most urgent, the emergence and spread of resistance to the drug artemisinin - the most commonly used drug against malaria - threatens to undo hard-fought gains, not o­nly in the region but worldwide. Artemisinin-resistant malaria could be globally devastating if it arises independently in other geographies or crosses more borders, especially to India, the gateway to Africa.

To deal with this public health emergency, a partnership of external funders, multilateral agencies, technical partners, scientific researchers, local communities and governments came into being. It's an audacious and o­ngoing goal, ripe with challenges and opportunities, and o­ne that calls o­n us to work with a clear mission and perseverance as we fight an elusive enemy.

The Global Fund partnership is backing a smart regional initiative with a US$100 million grant to tackle artemisinin resistance in Myanmar, Thailand, Viet Nam, Laos and Cambodia, with a special focus o­n mobile populations such as farming communities and seasonal agricultural workers.

The Regional Artemisinin-Resistance Initiative (RAI) has galvanized strong political commitment from East Asian leaders to achieve the goal of a malaria-free Asia Pacific by 2030. Countries are now saying that to end this devastating disease, control is not enough, and that to stamp out malaria we need to work together, with deeper cross border collaboration and regional data sharing.

Boost for regional efforts

To speed up the response to artemisinin resistance, the World Health Organization has developed a regional strategy for malaria elimination, providing a framework for all stakeholders. The investments have stimulated the use of innovative approaches to eliminate malaria, such as piloting mass drug administration in "hot spots" in hard-to-reach border populations along Thailand and Myanmar.

A significant number of people in low transmission areas harbour malaria parasites without apparent illness, detectable o­nly by highly sophisticated laboratory tests, meaning that conventional malaria activities cannot identify these people. Data from the mass drug administration pilot shows that the plan has been a success.

Other tools to roll back the disease include the use of malaria posts - simple structures that provide access to reliable diagnosis and effective treatment for any fever cases from the community - and the training of village health workers.

Disease elimination is not possible without strong community engagement and a high level of community participation. Eliminating malaria is not just about using the right drugs or the right insecticide-treated nets. It is also about trust and knowing the people we serve.

Similarly, no battle can be fought without enhanced surveillance and data analysis. Intelligence in real-time is crucial to adapt and respond effectively to a rapidly changing front-line, including the use of an o­n-line database system for continuous monitoring and for the sharing of information among all partners and stakeholders.

We still face big challenges. Malaria is well entrenched in communities, and the mosquito parasite and humans have evolved side by side. Resistance is an evolutionary phenomenon. Over time, as we attack malaria with a new drug the parasite fights back and develops resistance.

In Cambodia, the spread of resistance to artemisinin and also to the partner drug used in the combination therapy threatens to drive both drugs to uselessness. In such cases, the flexibility of the RAI structure allows us to follow national programs and change the partner drug.

Our ability to succeed will ultimately depend o­n the resilience of our partnerships. RAI is a terrific example of working together, in an interconnected world, to end malaria.

03/02/2016
(Source: news.trust.org)  

Announcement

LIBRARY
Book
Magazine
Document
Photos
Thesis
Documentary form
Research studies
PROFFESSIONAL SOFTWARE
Malaria forecast & management
Document management
Personel management
LEGAL DOCUMENTS
Law
Decision
Decree
Instruction
Circular
Official document
Reports
Others
SPECIFIED IMFORMATION
Malaria facts
Malaria epidemic
Petechial fever
HEALTH SERVICES
Hospital & medical centre
Drugstore
Surgery
Your doctor

Institue of Malariology Parastology and Entomology Quy Nhon
Address: 611B Nguyen Thai Hoc Str,. Quy Nhon City
Tel: (84) 056 846571 Fax: (84) 056 846755
• Designed by Quang Ich JSC